Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI

Polyurethanes (PU) are polymers made with diisocyanates such as MDI (4,4′-methylene diphenyl diisocyanate) and TDI (2,4-toluene diisocyanate and 2,6-toluene diisocyanate). Investigations have been undertaken with MDI and TDI to assess dermal uptake and resulting systemic exposure. Absorption, distri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology letters 2010-12, Vol.199 (3), p.364-371
Hauptverfasser: Hoffmann, H.D., Leibold, E., Ehnes, C., Fabian, E., Landsiedel, R., A.Gamer, Poole, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 371
container_issue 3
container_start_page 364
container_title Toxicology letters
container_volume 199
creator Hoffmann, H.D.
Leibold, E.
Ehnes, C.
Fabian, E.
Landsiedel, R.
A.Gamer
Poole, A.
description Polyurethanes (PU) are polymers made with diisocyanates such as MDI (4,4′-methylene diphenyl diisocyanate) and TDI (2,4-toluene diisocyanate and 2,6-toluene diisocyanate). Investigations have been undertaken with MDI and TDI to assess dermal uptake and resulting systemic exposure. Absorption, distribution and excretion of MDI was studied in rats using a single dermal administration of 14C-MDI dissolved in acetone at nominal 165 mg/kg body weight and 15 mg/kg bw (4.0 and 0.4 mg/cm 2) and intradermal injection of 14C-MDI dissolved in corn oil at nominal 1.4 mg/kg bw. Dermal absorption of 14C-MDI (at both doses) was low; at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. By intradermal administration of 14C-MDI approximately 66% of applied radioactivity remained at the application site with approximately 26% recovered in excreta, cage wash, tissues and carcass. The absorption, distribution and excretion of 2,4-TDI was studied in rats following a single dermal administration of radiolabelled 14C-2,4-TDI at nominal 350 mg/kg body weight (12 mg/cm 2). Dermal absorption of 14C-2,4-TDI was at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. In summary the results show that dermal uptake of MDI and TDI is very low. Due to the chemical reactivity of isocyanates it can be expected that small amounts which might be absorbed will react with tissue constituents directly at the exposed skin area, or will be converted to adducts with biomacromolecules or to biologically inactive oligoureas. Overall it is concluded that, following dermal exposure to MDI and TDI, systemic exposures and resulting toxicity, other than the known sensitization, can be expected to be very low. In addition studies were performed with dermal application of unlabelled 2,4 and 2,6 TDI to check the availability and fate of this chemical on rat skin surface and to assess possible tissue damage. These experiments showed that unchanged test material can be detected on rat skin for up to 8 h if not washed off. Dermal treatment with 2,4 or 2,6 TDI was associated with irritation with increased severity over a 48 h period after washing with a decontaminant solution.
doi_str_mv 10.1016/j.toxlet.2010.09.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_855694434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378427410017236</els_id><sourcerecordid>1762118833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3674-8297478c24e2bd6b9201f60dc01009b1d52c9d7ec1f1c0b1b9451feb09e282c73</originalsourceid><addsrcrecordid>eNp90c1u1DAQB_AIgei28AYI-YIohyy243z4Uglt-ahUxKWcLceZ7Hrx2sF2YPcN-1g4m6W99WTZ-nlmNP8se0PwkmBSfdwuo9sbiEuK0xPmS0zJs2xBmprnBan482yBi7rJGa3ZWXYewhZjXLGqfJmdUcyLIl0W2f01-J00aByi_AVI2g7BXnmI2lnkekTYKo_OjGABdVoHpw7SRkCXd9c3H458EjuIm4OZzbABezCPWE76-6S1RakVIC9jWKKV0Var1DrotQ3HUhsdohtk3Djj1gfUO2PcX23XqJuHhP3gwuhhGuyhEooOpWFeZS96aQK8Pp0X2c8vn-9W3_LbH19vVp9uc1VUNcsbymtWN4oyoG1XtTxtr69wp9ISMW9JV1LFuxoU6YnCLWk5K0kPLeZAG6rq4iJ7P9cdvPs9Qohip4MCY6QFNwbRlGXFGStYkpdPSlJXlJCmKYpE2UyVdyF46MXg9U76gyBYTGmLrZjTFlPaAnOR0k7f3p46jO0OuodP_-NN4N0JyJBW3XtplQ6PrigxZkd3NTtIm_ujwYugNFgFnfagouicfnqSf01wy18</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1762118833</pqid></control><display><type>article</type><title>Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hoffmann, H.D. ; Leibold, E. ; Ehnes, C. ; Fabian, E. ; Landsiedel, R. ; A.Gamer ; Poole, A.</creator><creatorcontrib>Hoffmann, H.D. ; Leibold, E. ; Ehnes, C. ; Fabian, E. ; Landsiedel, R. ; A.Gamer ; Poole, A.</creatorcontrib><description>Polyurethanes (PU) are polymers made with diisocyanates such as MDI (4,4′-methylene diphenyl diisocyanate) and TDI (2,4-toluene diisocyanate and 2,6-toluene diisocyanate). Investigations have been undertaken with MDI and TDI to assess dermal uptake and resulting systemic exposure. Absorption, distribution and excretion of MDI was studied in rats using a single dermal administration of 14C-MDI dissolved in acetone at nominal 165 mg/kg body weight and 15 mg/kg bw (4.0 and 0.4 mg/cm 2) and intradermal injection of 14C-MDI dissolved in corn oil at nominal 1.4 mg/kg bw. Dermal absorption of 14C-MDI (at both doses) was low; at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. By intradermal administration of 14C-MDI approximately 66% of applied radioactivity remained at the application site with approximately 26% recovered in excreta, cage wash, tissues and carcass. The absorption, distribution and excretion of 2,4-TDI was studied in rats following a single dermal administration of radiolabelled 14C-2,4-TDI at nominal 350 mg/kg body weight (12 mg/cm 2). Dermal absorption of 14C-2,4-TDI was at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. In summary the results show that dermal uptake of MDI and TDI is very low. Due to the chemical reactivity of isocyanates it can be expected that small amounts which might be absorbed will react with tissue constituents directly at the exposed skin area, or will be converted to adducts with biomacromolecules or to biologically inactive oligoureas. Overall it is concluded that, following dermal exposure to MDI and TDI, systemic exposures and resulting toxicity, other than the known sensitization, can be expected to be very low. In addition studies were performed with dermal application of unlabelled 2,4 and 2,6 TDI to check the availability and fate of this chemical on rat skin surface and to assess possible tissue damage. These experiments showed that unchanged test material can be detected on rat skin for up to 8 h if not washed off. Dermal treatment with 2,4 or 2,6 TDI was associated with irritation with increased severity over a 48 h period after washing with a decontaminant solution.</description><identifier>ISSN: 0378-4274</identifier><identifier>EISSN: 1879-3169</identifier><identifier>DOI: 10.1016/j.toxlet.2010.09.021</identifier><identifier>PMID: 20933064</identifier><identifier>CODEN: TOLED5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>2,4-Toluene diisocyanate ; 2,6-Toluene diisocyanate ; 4,4′-methylene diphenyl diisocyanate ; Animals ; Biological and medical sciences ; Carbon Radioisotopes ; Chemical and industrial products toxicology. Toxic occupational diseases ; Dermal uptake ; Diisocyanates ; Dissolution ; Excretion ; Isocyanates - pharmacokinetics ; Male ; Males ; MDI ; Medical sciences ; Polyurethane resins ; Radioactivity ; Rats ; Rats, Wistar ; Skin - drug effects ; Skin - metabolism ; Skin - pathology ; Solvents ; Toluene 2,4-Diisocyanate - pharmacokinetics ; Toluene 2,4-Diisocyanate - toxicity ; Toxicology ; Uptakes</subject><ispartof>Toxicology letters, 2010-12, Vol.199 (3), p.364-371</ispartof><rights>2010 Elsevier Ireland Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3674-8297478c24e2bd6b9201f60dc01009b1d52c9d7ec1f1c0b1b9451feb09e282c73</citedby><cites>FETCH-LOGICAL-c3674-8297478c24e2bd6b9201f60dc01009b1d52c9d7ec1f1c0b1b9451feb09e282c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.toxlet.2010.09.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23500464$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20933064$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoffmann, H.D.</creatorcontrib><creatorcontrib>Leibold, E.</creatorcontrib><creatorcontrib>Ehnes, C.</creatorcontrib><creatorcontrib>Fabian, E.</creatorcontrib><creatorcontrib>Landsiedel, R.</creatorcontrib><creatorcontrib>A.Gamer</creatorcontrib><creatorcontrib>Poole, A.</creatorcontrib><title>Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI</title><title>Toxicology letters</title><addtitle>Toxicol Lett</addtitle><description>Polyurethanes (PU) are polymers made with diisocyanates such as MDI (4,4′-methylene diphenyl diisocyanate) and TDI (2,4-toluene diisocyanate and 2,6-toluene diisocyanate). Investigations have been undertaken with MDI and TDI to assess dermal uptake and resulting systemic exposure. Absorption, distribution and excretion of MDI was studied in rats using a single dermal administration of 14C-MDI dissolved in acetone at nominal 165 mg/kg body weight and 15 mg/kg bw (4.0 and 0.4 mg/cm 2) and intradermal injection of 14C-MDI dissolved in corn oil at nominal 1.4 mg/kg bw. Dermal absorption of 14C-MDI (at both doses) was low; at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. By intradermal administration of 14C-MDI approximately 66% of applied radioactivity remained at the application site with approximately 26% recovered in excreta, cage wash, tissues and carcass. The absorption, distribution and excretion of 2,4-TDI was studied in rats following a single dermal administration of radiolabelled 14C-2,4-TDI at nominal 350 mg/kg body weight (12 mg/cm 2). Dermal absorption of 14C-2,4-TDI was at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. In summary the results show that dermal uptake of MDI and TDI is very low. Due to the chemical reactivity of isocyanates it can be expected that small amounts which might be absorbed will react with tissue constituents directly at the exposed skin area, or will be converted to adducts with biomacromolecules or to biologically inactive oligoureas. Overall it is concluded that, following dermal exposure to MDI and TDI, systemic exposures and resulting toxicity, other than the known sensitization, can be expected to be very low. In addition studies were performed with dermal application of unlabelled 2,4 and 2,6 TDI to check the availability and fate of this chemical on rat skin surface and to assess possible tissue damage. These experiments showed that unchanged test material can be detected on rat skin for up to 8 h if not washed off. Dermal treatment with 2,4 or 2,6 TDI was associated with irritation with increased severity over a 48 h period after washing with a decontaminant solution.</description><subject>2,4-Toluene diisocyanate</subject><subject>2,6-Toluene diisocyanate</subject><subject>4,4′-methylene diphenyl diisocyanate</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carbon Radioisotopes</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Dermal uptake</subject><subject>Diisocyanates</subject><subject>Dissolution</subject><subject>Excretion</subject><subject>Isocyanates - pharmacokinetics</subject><subject>Male</subject><subject>Males</subject><subject>MDI</subject><subject>Medical sciences</subject><subject>Polyurethane resins</subject><subject>Radioactivity</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Skin - drug effects</subject><subject>Skin - metabolism</subject><subject>Skin - pathology</subject><subject>Solvents</subject><subject>Toluene 2,4-Diisocyanate - pharmacokinetics</subject><subject>Toluene 2,4-Diisocyanate - toxicity</subject><subject>Toxicology</subject><subject>Uptakes</subject><issn>0378-4274</issn><issn>1879-3169</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90c1u1DAQB_AIgei28AYI-YIohyy243z4Uglt-ahUxKWcLceZ7Hrx2sF2YPcN-1g4m6W99WTZ-nlmNP8se0PwkmBSfdwuo9sbiEuK0xPmS0zJs2xBmprnBan482yBi7rJGa3ZWXYewhZjXLGqfJmdUcyLIl0W2f01-J00aByi_AVI2g7BXnmI2lnkekTYKo_OjGABdVoHpw7SRkCXd9c3H458EjuIm4OZzbABezCPWE76-6S1RakVIC9jWKKV0Var1DrotQ3HUhsdohtk3Djj1gfUO2PcX23XqJuHhP3gwuhhGuyhEooOpWFeZS96aQK8Pp0X2c8vn-9W3_LbH19vVp9uc1VUNcsbymtWN4oyoG1XtTxtr69wp9ISMW9JV1LFuxoU6YnCLWk5K0kPLeZAG6rq4iJ7P9cdvPs9Qohip4MCY6QFNwbRlGXFGStYkpdPSlJXlJCmKYpE2UyVdyF46MXg9U76gyBYTGmLrZjTFlPaAnOR0k7f3p46jO0OuodP_-NN4N0JyJBW3XtplQ6PrigxZkd3NTtIm_ujwYugNFgFnfagouicfnqSf01wy18</recordid><startdate>20101215</startdate><enddate>20101215</enddate><creator>Hoffmann, H.D.</creator><creator>Leibold, E.</creator><creator>Ehnes, C.</creator><creator>Fabian, E.</creator><creator>Landsiedel, R.</creator><creator>A.Gamer</creator><creator>Poole, A.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>KR7</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20101215</creationdate><title>Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI</title><author>Hoffmann, H.D. ; Leibold, E. ; Ehnes, C. ; Fabian, E. ; Landsiedel, R. ; A.Gamer ; Poole, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3674-8297478c24e2bd6b9201f60dc01009b1d52c9d7ec1f1c0b1b9451feb09e282c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>2,4-Toluene diisocyanate</topic><topic>2,6-Toluene diisocyanate</topic><topic>4,4′-methylene diphenyl diisocyanate</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carbon Radioisotopes</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Dermal uptake</topic><topic>Diisocyanates</topic><topic>Dissolution</topic><topic>Excretion</topic><topic>Isocyanates - pharmacokinetics</topic><topic>Male</topic><topic>Males</topic><topic>MDI</topic><topic>Medical sciences</topic><topic>Polyurethane resins</topic><topic>Radioactivity</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Skin - drug effects</topic><topic>Skin - metabolism</topic><topic>Skin - pathology</topic><topic>Solvents</topic><topic>Toluene 2,4-Diisocyanate - pharmacokinetics</topic><topic>Toluene 2,4-Diisocyanate - toxicity</topic><topic>Toxicology</topic><topic>Uptakes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoffmann, H.D.</creatorcontrib><creatorcontrib>Leibold, E.</creatorcontrib><creatorcontrib>Ehnes, C.</creatorcontrib><creatorcontrib>Fabian, E.</creatorcontrib><creatorcontrib>Landsiedel, R.</creatorcontrib><creatorcontrib>A.Gamer</creatorcontrib><creatorcontrib>Poole, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Civil Engineering Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Toxicology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoffmann, H.D.</au><au>Leibold, E.</au><au>Ehnes, C.</au><au>Fabian, E.</au><au>Landsiedel, R.</au><au>A.Gamer</au><au>Poole, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI</atitle><jtitle>Toxicology letters</jtitle><addtitle>Toxicol Lett</addtitle><date>2010-12-15</date><risdate>2010</risdate><volume>199</volume><issue>3</issue><spage>364</spage><epage>371</epage><pages>364-371</pages><issn>0378-4274</issn><eissn>1879-3169</eissn><coden>TOLED5</coden><abstract>Polyurethanes (PU) are polymers made with diisocyanates such as MDI (4,4′-methylene diphenyl diisocyanate) and TDI (2,4-toluene diisocyanate and 2,6-toluene diisocyanate). Investigations have been undertaken with MDI and TDI to assess dermal uptake and resulting systemic exposure. Absorption, distribution and excretion of MDI was studied in rats using a single dermal administration of 14C-MDI dissolved in acetone at nominal 165 mg/kg body weight and 15 mg/kg bw (4.0 and 0.4 mg/cm 2) and intradermal injection of 14C-MDI dissolved in corn oil at nominal 1.4 mg/kg bw. Dermal absorption of 14C-MDI (at both doses) was low; at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. By intradermal administration of 14C-MDI approximately 66% of applied radioactivity remained at the application site with approximately 26% recovered in excreta, cage wash, tissues and carcass. The absorption, distribution and excretion of 2,4-TDI was studied in rats following a single dermal administration of radiolabelled 14C-2,4-TDI at nominal 350 mg/kg body weight (12 mg/cm 2). Dermal absorption of 14C-2,4-TDI was at or below 1% of the applied dose. Considerable amounts of the applied radioactivity were found at the application site which could not be washed off. In summary the results show that dermal uptake of MDI and TDI is very low. Due to the chemical reactivity of isocyanates it can be expected that small amounts which might be absorbed will react with tissue constituents directly at the exposed skin area, or will be converted to adducts with biomacromolecules or to biologically inactive oligoureas. Overall it is concluded that, following dermal exposure to MDI and TDI, systemic exposures and resulting toxicity, other than the known sensitization, can be expected to be very low. In addition studies were performed with dermal application of unlabelled 2,4 and 2,6 TDI to check the availability and fate of this chemical on rat skin surface and to assess possible tissue damage. These experiments showed that unchanged test material can be detected on rat skin for up to 8 h if not washed off. Dermal treatment with 2,4 or 2,6 TDI was associated with irritation with increased severity over a 48 h period after washing with a decontaminant solution.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>20933064</pmid><doi>10.1016/j.toxlet.2010.09.021</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-4274
ispartof Toxicology letters, 2010-12, Vol.199 (3), p.364-371
issn 0378-4274
1879-3169
language eng
recordid cdi_proquest_miscellaneous_855694434
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 2,4-Toluene diisocyanate
2,6-Toluene diisocyanate
4,4′-methylene diphenyl diisocyanate
Animals
Biological and medical sciences
Carbon Radioisotopes
Chemical and industrial products toxicology. Toxic occupational diseases
Dermal uptake
Diisocyanates
Dissolution
Excretion
Isocyanates - pharmacokinetics
Male
Males
MDI
Medical sciences
Polyurethane resins
Radioactivity
Rats
Rats, Wistar
Skin - drug effects
Skin - metabolism
Skin - pathology
Solvents
Toluene 2,4-Diisocyanate - pharmacokinetics
Toluene 2,4-Diisocyanate - toxicity
Toxicology
Uptakes
title Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A40%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dermal%20uptake%20and%20excretion%20of%2014C-toluene%20diisocyante%20(TDI)%20and%2014C-methylene%20diphenyl%20diisocyanate%20(MDI)%20in%20male%20rats.%20Clinical%20signs%20and%20histopathology%20following%20dermal%20exposure%20of%20male%20rats%20to%20TDI&rft.jtitle=Toxicology%20letters&rft.au=Hoffmann,%20H.D.&rft.date=2010-12-15&rft.volume=199&rft.issue=3&rft.spage=364&rft.epage=371&rft.pages=364-371&rft.issn=0378-4274&rft.eissn=1879-3169&rft.coden=TOLED5&rft_id=info:doi/10.1016/j.toxlet.2010.09.021&rft_dat=%3Cproquest_cross%3E1762118833%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1762118833&rft_id=info:pmid/20933064&rft_els_id=S0378427410017236&rfr_iscdi=true